OIG Study Examines Drug Supply Chain Security, Focuses on Dispensers’ Receipt of Drug Product Tracing Information – Drug for nerve pain boosts high for opioid abusers.

16513-PHARMACY BOARD-standard-041216Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

OIG Study Examines Drug Supply Chain Security, Focuses on Dispensers’ Receipt of Drug Product Tracing Information – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Overall, dispensers are generally implementing the drug product tracing requirements under the Drug Supply Chain Security Act (DSCSA), according to the results of a study conducted by the Office of Inspector General (OIG). However, missing information and a lack of awareness of DSCSA requirements raise concerns that a complete tracing record for a drug product may not always be available to support investigations of suspect and illegitimate drug products in the supply chain, indicates OIG.

The study focused on dispensers’ receipt of drug product tracing information because this most represents their role at the end of the drug supply chain. The OIG selected 40 dispensers – 15 small independent retail pharmacies, 15 large chain retail pharmacies, five small inpatient hospital pharmacies, and five large inpatient hospitals – and collected data nine months after FDA began enforcing the dispenser drug product tracing requirements, between December 2016 and February 2017.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.